Dr Reddy, Q4
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript
Dr. Reddy's Laboratories Limited (NYSE: RDY) Q4 2024 Earnings Call Transcript May 7, 2024
Doctor Reddy’s: Fiscal Q4 Earnings Snapshot
(RDY) on Tuesday reported net income of $157 million in its fiscal fourth quarter. The Hyderabad, India-based company
India's Dr Reddy's beats Q4 profit estimates
Indian generic drugmaker Dr Reddy's Laboratories reported fourth-quarter profit above expectations on Tuesday, driven by strong sales in its key U.S. and European markets.
Dr Reddy's share price falls 5% after Q4 results: What brokerages said
Dr Reddy's said that its net profit was 3% lower sequentially compared to ₹13,738 crore seen in the December'2023 quarter.
Dr Reddy's healthy Q4 results fail to impress brokerages amid lack of growth triggers
Dr Reddy's Labs' healthy Q4 numbers could not impress brokerages as analysts warned of a lack of near-term growth triggers for the drugmaker. While Dr Reddy's remains focused on biosimilars and initiatives to strengthen its business in key markets,
Dr Reddy's Q4 net profit up 36%
HYDERABAD: Pharma major Dr Reddy’s Laboratories on Tuesday said it has posted a 36% jump in consolidated profit after tax (PAT) for the fourth quarter ended March 31, 2024, at Rs 1,307 crore as against Rs 959 crore in the corresponding quarter of financial year 2022-23 (FY23).
Dr Reddy's Lab Q4FY24 net profit up 36% YoY to Rs 1,307 cr
Hyderabad-based pharma major Dr Reddys Laboratories recorded a net profit of Rs 1,307 crore in the March quarter of FY24, up 36 percent from the same period last year when it reported a profit of Rs 960 crore.
Dr Reddy’s Q4 net profit rises 36% to ₹1,307 crore, surpasses market expectations
FY24, DRL reported a net profit of ₹5,568.4 crore, a 36% increase, and total revenues of ₹27,920 crore, up 14% on year, led by performances in North America, Europe, and emerging markets.
iBuyPower Scale RDY PC Review: The Minimum You Need for Great Gaming
If Conan the Barbarian was a desktop gaming PC enthusiast, and you asked him what is best in life, his answer would probably ...
Nasdaq13h
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
RDY received a Complete Response Letter from the FDA for its ... has remained constant at $4.56 and $5.27, respectively. Shares of LGND are up 2.5% year to date. In the past 60 days, estimates ...
Seeking Alpha1mon
RDY Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and ...
Save Up to 50% on Adidas’ Most Iconic Sneakers and Activewear This Week Only
Below, shop the best finds for men and women from the Adidas sale. Shop sneakers, running shorts, leggings and more just in ...
Morningstar5d
Dr Reddy's Laboratories Ltd ADR RDY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Hosted on MSN12mon
Adidas Terrex WMN Mid rain.RDY Hiking Shoes review: stylish, supportive outdoor footwear for women
Adidas Terrex WMN Mid rain.RDY Hiking Shoes review in a sentence: well-designed outdoor footwear suitable for women that like to explore in style with comfort and support at the top of their list.
The Best New Gadgets of April 2024
We hope you like TVs because that’s what April had to deliver in 2024. Samsung showed off its latest Neo QLED 4K TV, while ...
Morningstar2d
Teva Pharmaceutical Industries Ltd ADR TEVA
New products including Ajovy, Austedo (daily and extended release), and Uzedy will fuel Teva’s top and bottom lines as their adoption increases. The majority of Teva's business lies in generic ...
Yahoo Finance20d
Dr. Reddy's Laboratories Limited (RDY)
Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart ...